Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

ClinicalTrials.gov ID: NCT03793010

Public ClinicalTrials.gov record NCT03793010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 5:44 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a two-part, multi-center, randomized, double-blind, placebo-controlled, parallel-group study in patients with hip OA. Approximately 70 patients will be enrolled in Part I and approximately 440 patients will be enrolled in Part II of the study. In each part, patients will be randomized to one of two treatment groups (1:1) and treated with a single IA injection of either 32 mg FX006 or normal saline.

Study identification

NCT ID
NCT03793010
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2018 (Actual)
Primary completion
Aug 7, 2019 (Actual)
Completion
Aug 7, 2019 (Actual)
Last update posted
Jan 24, 2024

2018 – 2019

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053 —
Noble Clinical Research Tucson Arizona 85704 —
Hope Clinical Research Canoga Park California 91303 —
TriWest Research Associates, LLC El Cajon California 92020 —
BioSolutions Clinical Research Center La Mesa California 91942 —
Artemis Institute for Clinical Research San Diego California 92103 —
Mountain View Clinical Research, Inc. Denver Colorado 80209 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Tampa Bay Medical Research Clearwater Florida 33761 —
Florida Research Associates, LLC DeLand Florida 32720 —
Advanced Research for Health Improvement Naples Florida 34102 —
Medallion Clinical Research Institute, LLC Naples Florida 34102 —
Oviedo Medical Research Oviedo Florida 32765 —
Progressive Medical Research Port Orange Florida 32127 —
Precision Clinical Research, LLC Sunrise Florida 33351 —
National Pain Research Institute Winter Park Florida 32789 —
Better Health Clinical Research, Inc Newnan Georgia 30265 —
Injury Care Research, LLC Boise Idaho 83713 —
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
Heartland Research Associates Newton Kansas 67114 —
Excel Clinical Research Las Vegas Nevada 89109 —
Drug Trials America Hartsdale New York 10530 —
M3 Wake Research, Inc. Raleigh North Carolina 27612 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
University Orthopedics Center Altoona Pennsylvania 16602 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Clinical Trials of South Carolina Charleston South Carolina 29406 —
Coastal Carolina Research Center Charleston South Carolina 29406 —
Wasatch Clinical Research, LLC Salt Lake City Utah 84107 —
Charlottesville Medical Research Charlottesville Virginia 22911 —
Spectrum Medical, Inc. Danville Virginia 24541 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03793010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2024 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03793010 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →